Macrocyclics, Inc. (an AREVA Med company) announced today the launch of newoffices located in China, Japan, South Korea, and France. The productionlaboratory remains based in Dallas, Texas, USA; however, Asian and Frenchcustomers will now have a local contact for placing orders and obtainingtechnical information about all products and services available fromMacrocyclics, and the ability to communicate in their own language as well asEnglish.
To reach Macrocyclics in their new offices, please use the following:
Beijing, China Tokyo, JapanMrs. Carrie SONG Mr. Sebastien PAES+86-150-1146-1640 +81-90-2620-5448china@macrocyclics.com japan@macrocyclics.com
Seoul, South Korea Limoges, FranceMrs. Hye-Young PARK Mr. Remy DUREAU+82-2-551-01-65 +33-6-46-42-45-65southkorea@macrocyclics.com france@macrocyclics.com
Macrocyclics specializes in the manufacture of customized chelating agentsused in nuclear medicine and medical imaging. We also offer custom-made cGMPproducts for use in clinical trials, bioconjugation services, and consultingservices that will help our customers select the proper isotopes for theirparticular needs.
Please visit http://www.macrocyclics.com for detailed information.